Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA splicing machinery, or spliceosome, is a large ribonucleoprotein complex responsible for removing introns from pre-mRNA and ligating exons. It consists of five snRNPs (U1, U2, U4, U5, U6) and over 300 associated proteins. It plays a crucial role in gene expression and proteomic diversity through alternative splicing. Dysregulation of splicing is implicated in various diseases, including cancer.
Modulation of RNA splicing
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA Splicing Machinery (Spliceosome).